Search Results

GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide.

MIM Software Inc., a leading global provider of medical imaging software, is bringing its personalized dosimetry application to a growing majority of healthcare centers, providing clinicians and patients with advanced treatment insights.

MIM Software Inc. is proud to support the efforts of the Melbourne Theronastic Innovation Centre (MTIC) in Melbourne, Victoria as they launch the use of the Siemens Biograph Vision Quadra PET/CT, one of the few such “all-organ” scanners in the world.

MIM Software Inc. and Videra Surgical Inc. have announced a collaboration involving Videra Surgical’s VeraForm® tumor bed marker and MIM Software’s platform for Radiation Oncology.

Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and MIM Software Inc. (“MIM Software”), a leading global provider of medical imaging software, announced a collaboration between the two companies to provide treatment planning software for clinical sites using the Alpha DaRT therapy.

Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III FRONTIER3 trial. The company plans to file for approval this year, hoping to compete in the hemophilia A space with Roche’s blockbuster Hemlibra.

MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy.